Pharmaceutical

IO360 summit: CAR-T cell therapy applications beyond blood cancer

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment.

Apr 4, 2025 - 06:00
IO360 summit: CAR-T cell therapy applications beyond blood cancer
Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment.
Read the original article

Tags:

Previous Article

Atsena closes $150m in Series C round to progress gene therapy

Next Article

Pharma industry dodges tariff blow but still braces for disruption

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Reform in South Korea means progression in improving time to reimbursement

Reform in South Korea means progression in improving ti...

Nov 14, 2023

Monoclonal Antibody Conjugate 3 to Target EGFR for Onco...

Feb 8, 2024

STAT+: After Sarepta trial failure, families and doctors brace for another debate on Duchenne therapy

STAT+: After Sarepta trial failure, families and doctor...

Nov 1, 2023